For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks ...

Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over ...

Law firm Araoz y Rueda has been independently engaged by several international and Spanish institutions (the "Clients") holding in aggregate 5.65% of A shares and 3.88% of B shares (including ADRs) in ...

Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma ...

Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

MADRID, Nov 27 (Reuters) - Canadian fund Brookfield (BAM.TO), opens new tab said on Wednesday it has dropped its plan to take over Spain's Grifols (GRLS.MC), opens new tab due to a disagreement ...

Brookfield withdrew its bid for the Spanish pharmaceutical company following a deadlock between the two side over price ...

On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a ...

Shares of Grifols GRFS lost over 7% on Wednesday after the company announced that Canada-based Brookfield Asset Management has withdrawn its plan to acquire it. Both parties likely failed to ...

Grifols shares fell as much as 14 per cent after the news was published by Bloomberg, the biggest intra-day decline since Feb ...